Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743790 · ClinicalTrials.gov registry record · NA
The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT05743790: Completed NA study, sponsored by Cornell University.
NCT05743790 is a NA study that has completed, run by Cornell University. The registered enrollment target is 196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743790, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
Resistant starch (RS), a type of dietary fiber, was shown to have beneficial effects on human health through its impact on microbes present in the intestine. However, the effects of RS on the gut microbiota and in turn, on human health, can vary between individuals. Consequently, everyone may not reap the same health benefits by eating high amounts of RS. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes respond to RS supplementation would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber intake. The objective of this study was to evaluate candidate predictors of gut microbiota response to RS supplementation.
Primary Outcome
16S rRNA gene survey of gut microbial communities
Interventions
- DIETARY_SUPPLEMENT RS2-control-RS4
- DIETARY_SUPPLEMENT RS4-control-RS2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
What the finished NCT05743790 record still lists
NCT05743790 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which RS2-control-RS4 is the first listed.
NCT05743790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05743790 about?
NCT05743790 is a clinical study titled "The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption". Resistant starch (RS), a type of dietary fiber, was shown to have beneficial effects on human health through its impact on microbes present in the intestine. However, the effects of RS on the gut microbiota and in turn, on human health, can vary between individuals. Consequently, everyone may not re...
What is the current status of trial NCT05743790?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2019-09-26. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT05743790?
The interventions under investigation include: RS2-control-RS4 (DIETARY_SUPPLEMENT), RS4-control-RS2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05743790?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05743790's enrollment target sits among peer trials
196 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI